We are live on ! Find out more
LHDX

Lucira Health, Inc. Common Stock
LHDX

Delisted

LHDX was delisted on the 3rd of March, 2023.

Back to rankings

1 hedge funds and large institutions have $321 invested in Lucira Health, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Resolute Advisors
California
+$321

Top Sellers

No sellers this quarter

LHDX Hedge Fund Activity: Q4 2023 in Review

1 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q4 2023, worth a combined $321.

Buyers outnumbered sellers: 1 fund opened new LHDX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Resolute Advisors, opening a new position worth an estimated $321.

  • 1 institutional investor held Lucira Health, Inc. Common Stock (LHDX) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $321 of Lucira Health, Inc. Common Stock stock for Q4 2023.
  • 1 fund opened new Lucira Health, Inc. Common Stock positions in Q4 2023 and 0 closed out, a net change of +1 holder.
  • The largest Lucira Health, Inc. Common Stock buyer in Q4 2023 was Resolute Advisors, an estimated $321 added.

Based on aggregated 13F filings for Q4 2023.